FDA Adverse Event Malfunction Summary report: N

UNSPECIFIED BD INFUSION SET

MDR report key: 22955971 · Received September 3, 2025

Report

Report Number
9616066-2025-02650
Event Type
Malfunction
Date Received
September 3, 2025
Date of Event
August 7, 2025
Report Date
October 30, 2025
Manufacturer
SISTEMAS MEDICOS ALARIS S.A. DE C.V.
Product Code
FPA
PMA / PMN Number
UNKNOWN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

B.3. THE DATE OF EVENT IS UNKNOWN; BD AWARENESS DATE USED. E.1. ADDRESS WAS NOT LOCATED, AND IL WAS USED. H.3. IF A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS COMPLETED, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

INVESTIGATION RESULTS: DUE TO NO SAMPLE BEING RECEIVED, AN INVESTIGATION COULD NOT BE PERFORMED, AND A ROOT CAUSE COULD NOT BE DETERMINED. NO PRODUCT WILL BE RETURNED PER CUSTOMER. NO INVESTIGATION WAS PERFORMED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE UNSPECIFIED BD INFUSION SET HAD FOREIGN MATTER. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: THE CONNECTION/DISCONNECTION TEST SHOWED THAT ALTHOUGH ALL THE DEVICES COMPLIED WITH THE CURRENT STANDARD, THERE WAS A STATISTICALLY SIGNIFICANT DIFFERENCE IN THE MEAN ±STANDARD DEVIATION COMPRESSION FORCE (51.5 ±11.6 FOR THE CONNECT-ZTM VS. 60.3±11.7 FOR THE CHEMOLOCKTM; P=0.0005). THE CONTAMINATION RATES WERE SIGNIFICANTLY DIFFERENT: (B)(4) FOR THE BD PHASEALTM VERSUS (B)(4) FOR THE CHEMOLOCKTM; P < 0.0001).

Description of Event or Problem · 0

NO ADDITIONAL INFORMATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1734103 UNSPECIFIED BD INFUSION SET INTRAVASCULAR ADMINISTRATION SET FPA SISTEMAS MEDICOS ALARIS S.A. DE C.V. UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown